L-lysine as adjunctive treatment in patients with schizophrenia: a single-blinded, randomized, cross-over pilot study

BACKGROUND: Accumulating evidence suggests that the brain's nitric oxide (NO) signalling system may be involved in the pathophysiology of schizophrenia and could thus constitute a novel treatment target. The study was designed to investigate the benefit of L-lysine, an amino acid that interfere...

Descripción completa

Detalles Bibliográficos
Autores principales: Wass, Caroline, Klamer, Daniel, Katsarogiannis, Evangelos, Pålsson, Erik, Svensson, Lennart, Fejgin, Kim, Bogren, Inga-Britt, Engel, Jörgen A, Rembeck, Birgitta
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3094237/
https://www.ncbi.nlm.nih.gov/pubmed/21501494
http://dx.doi.org/10.1186/1741-7015-9-40

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3094237/
https://www.ncbi.nlm.nih.gov/pubmed/21501494
http://dx.doi.org/10.1186/1741-7015-9-40

Ejemplares similares